CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP
CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP

Coronavirus: fifth Chinese Covid-19 vaccine candidate ready to enter phase 3 trials

  • Anhui Zhifei Longcom Biopharmaceutical looks to recruit 29,000 people for final tests, first of which will start this month in Uzbekistan
  • Announcement comes as China National Biotec Group says it is preparing to review the results of final stage trials of two of its products

Topic |   Coronavirus China
CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP
CNBG is expecting a partial review of its phase 3 clinical trials on Friday. Photo: AP
READ FULL ARTICLE